Proto-Oncogene Proteins c-vav
"Proto-Oncogene Proteins c-vav" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that are guanine nucleotide exchange factors for RHO GTPASES. They contain pleckstrin homology and SH2 domains, through which they function as signal transducing adaptor proteins.
| Descriptor ID |
D051567
|
| MeSH Number(s) |
D12.644.360.024.321 D12.644.360.325.300.099.750 D12.776.157.057.155 D12.776.476.024.407 D12.776.476.325.300.099.750 D12.776.624.664.700.198
|
| Concept/Terms |
Proto-Oncogene Proteins c-vav- Proto-Oncogene Proteins c-vav
- Proteins c-vav, Proto-Oncogene
- Proto Oncogene Proteins c vav
- c-vav, Proto-Oncogene Proteins
- Proto-Oncogene Protein vav
- Proto Oncogene Protein vav
- vav, Proto-Oncogene Protein
- vav Proto-Oncogene Protein
- Proto-Oncogene Protein, vav
- vav Proto Oncogene Protein
- c-vav Protein
- c vav Protein
- Proto-Oncogene Protein vav1
- Proto Oncogene Protein vav1
- vav1, Proto-Oncogene Protein
- vav Guanine-Nucleotide Exchange Factor
- vav Guanine Nucleotide Exchange Factor
- Proto-Oncogene Protein c-vav
- Proto Oncogene Protein c vav
- c-vav, Proto-Oncogene Protein
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-vav".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-vav".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-vav" by people in this website by year, and whether "Proto-Oncogene Proteins c-vav" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-vav" by people in Profiles.
-
Immunohistochemical analysis of the natural killer cell cytotoxicity pathway in human abdominal aortic aneurysms. Int J Mol Sci. 2015 May 18; 16(5):11196-212.
-
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):E59-67.
-
ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling. Blood. 2010 Oct 28; 116(17):3208-18.
-
Vav and Rac activation in B cell antigen receptor endocytosis involves Vav recruitment to the adapter protein LAB. J Biol Chem. 2009 Dec 25; 284(52):36202-36212.
-
B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. J Biol Chem. 2009 Sep 04; 284(36):24088-97.
-
Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system. J Immunol. 2007 Apr 15; 178(8):5366-74.
-
Vav activation and function as a rac guanine nucleotide exchange factor in macrophage colony-stimulating factor-induced macrophage chemotaxis. Mol Cell Biol. 2005 May; 25(10):4211-20.
-
Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions. J Immunol. 1997 Feb 01; 158(3):1125-32.
-
Molecular analysis of Ras activation by tyrosine phosphorylated Vav. Biochem Biophys Res Commun. 1995 Dec 26; 217(3):876-85.
-
Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol. 1994 Jul; 14(7):4749-58.